IMGN
Immunogen Inc
IMGN
IMGN
Delisted
IMGN was delisted on the 9th of February, 2024.
198 hedge funds and large institutions have $1.22B invested in Immunogen Inc in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 74 increasing their positions, 55 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
3% less funds holding
Funds holding: 204 → 198 (-6)
13% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 32
Holders
198
Holding in Top 10
1
Calls
$8.07M
Puts
$8.01M
Top Buyers
1 | +$38.2M | |
2 | +$25.4M | |
3 | +$21.5M | |
4 |
BlackRock
New York
|
+$20.2M |
5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$20M |
Top Sellers
1 | -$17.6M | |
2 | -$13.4M | |
3 | -$9.1M | |
4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$7.26M |
5 |
Invesco
Atlanta,
Georgia
|
-$7.1M |